These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 30676535

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cannabinoids in treatment-resistant epilepsy: A review.
    O'Connell BK, Gloss D, Devinsky O.
    Epilepsy Behav; 2017 May; 70(Pt B):341-348. PubMed ID: 28188044
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
    Hussain SA, Zhou R, Jacobson C, Weng J, Cheng E, Lay J, Hung P, Lerner JT, Sankar R.
    Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
    [Abstract] [Full Text] [Related]

  • 7. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.
    Lattanzi S, Trinka E, Striano P, Rocchi C, Salvemini S, Silvestrini M, Brigo F.
    CNS Drugs; 2021 Mar; 35(3):265-281. PubMed ID: 33754312
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies.
    Reddy DS.
    Exp Neurol; 2023 Jan; 359():114237. PubMed ID: 36206806
    [Abstract] [Full Text] [Related]

  • 9. The role of cannabinoids in epilepsy treatment: a critical review of efficacy results from clinical trials.
    Nabbout R, Thiele EA.
    Epileptic Disord; 2020 Jan 01; 22(S1):23-28. PubMed ID: 31916540
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
    Golub V, Reddy DS.
    Adv Exp Med Biol; 2021 Jan 01; 1264():93-110. PubMed ID: 33332006
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cannabidiol reveals a disruptive strategy for 21st century epilepsy drug discovery.
    Del Pozo A, Barker-Haliski M.
    Exp Neurol; 2023 Feb 01; 360():114288. PubMed ID: 36471511
    [Abstract] [Full Text] [Related]

  • 17. Use of cannabidiol in the treatment of epilepsy.
    Mazurkiewicz-Bełdzińska M, Zawadzka M.
    Neurol Neurochir Pol; 2022 Feb 01; 56(1):14-20. PubMed ID: 35211946
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The Utility of Cannabidiol in the Treatment of Refractory Epilepsy.
    Reddy DS.
    Clin Pharmacol Ther; 2017 Feb 01; 101(2):182-184. PubMed ID: 27506704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.